Shanghai Bronze Award for Outstanding Invention Went in North Carolina
Release time:
2020-07-31
News from this newspaper The results of the 31 Shanghai Excellent Invention Trial jointly organized by the Shanghai Federation of Trade Unions, the Shanghai Intellectual Property Office, the Shanghai Municipal Committee of the Communist Youth League, the Shanghai Science and Technology Association, and the Shanghai Invention Association were evaluated a few days ago, shanghai Beika Pharmaceutical Technology Co., Ltd. declared "Erlotinib Hydrochloride and Its Advanced Intermediate Quality Improvement and Industrialization Optimization " won the bronze award.
erlotinib hydrochloride is a targeted therapeutic drug for the treatment of non-small cell lung cancer, which can prolong the survival time and improve the quality of life of lung cancer patients. It can target and specific action sites to kill tumor cells, and has little impact on normal tissues. It belongs to the biological and new medical technology in the high-tech field supported by the state. In this invention, 6,7- dimethoxyquinazoline -4- ketone, 4- chlorine -6,7- bis (2- methoxyethoxy) quinazoline and 3- aminophenylacetylene are important intermediates of erlotinib hydrochloride, the latter is also an important intermediate of icotinib hydrochloride, the first new anti-tumor drug in China. The invention designs and adopts a new synthesis process route, which can effectively reduce the cost of raw materials, the reactions are mostly aqueous phase reactions, the energy consumption and three waste emissions are reduced by about 35% , the industrialization conditions are optimized, the product quality is improved, and it is applied to industrial mass production, which is conducive to the production of high-quality and low-cost erlotinib hydrochloride drugs and the economic burden of patients is reduced.
Shanghai Excellent Invention Contest was founded in 1987 . It is an important scientific and technological award approved by the Shanghai municipal government. It not only strongly promotes the majority of employees to carry out invention and creation activities based on their posts, but also improves the independent innovation ability of the unit. Taking this award as an opportunity, Shanghai North Carolina will further focus on small molecule chemical innovative drugs and characteristic chemical intermediates, continue to build a high-level technology platform around the key links of new drug research and development, and cultivate scientific and technological innovation teams. (Fang Yuyu)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page